Results 161 to 170 of about 68,390 (380)

Sex‐Based Differences in Noncommunicable Diseases in Older Adults: Raising the Profile of Older Females

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Aathmika Nandan   +2 more
wiley   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

Napping during cognitive behavioural therapy for insomnia: Friends or foes?

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Cognitive and Behavioural Therapy for Insomnia (CBT‐I) is the gold standard treatment for chronic insomnia, with one crucial step being the restriction of time spent in bed. This restriction often intensifies early afternoon sleepiness, leading to a natural gateway for a short recuperative nap, which might foster adherence to CBT‐I over time ...
Brice Faraut   +5 more
wiley   +1 more source

Diagnosis of Sleep Apnea Hypopnea Syndrome Using Fusion of Micro-motion Signals from Millimeter-wave Radar and Pulse Wave Data

open access: yesLeida xuebao
Sleep Apnea Hypopnea Syndrome (SAHS) is a common chronic sleep-related breathing disorder that affects individuals’ sleep quality and physical health. This article presents a sleep apnea and hypopnea detection framework based on multisource signal fusion.
Xiang ZHAO   +4 more
doaj   +1 more source

The Effects of Daridorexant on Patients With Comorbid Insomnia Disorder and Untreated Mild Obstructive Sleep Apnoea: A Post Hoc Subgroup Analysis of a Phase 3, Randomised Clinical Trial

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri   +8 more
wiley   +1 more source

Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma [PDF]

open access: bronze, 2009
Joanne Y. Julien   +9 more
openalex   +1 more source

Effect of Liraglutide on Intermittent Hypoxia‐Induced Metabolic Dysfunction: From Bench to Bedside

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Intermittent hypoxia (IH)‐mediated adipose tissue inflammation with M1 macrophage polarisation plays a key role in the pathogenesis of metabolic diseases in obstructive sleep apnoea (OSA). Effective treatment strategies are so far lacking.
Cliona O'Donnell   +11 more
wiley   +1 more source

Childhood OSAS and Obesity: Prospective Associations of Anthropometric Markers With Objective Sleep Outcomes in the CHAT Trial

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Obstructive sleep apnea syndrome (OSAS) is characterised by episodic upper airway obstruction that occurs during sleep and is common in children with obesity. The aim of the present study was to analyse the association between baseline anthropometric markers and objective sleep quality measures at follow‐up in school‐aged children with OSAS ...
Catalina Ramírez‐Contreras   +2 more
wiley   +1 more source

Analysis of main caregivers′ burden and needs for nursing knowledge in children with obstructive sleep apnea hypopnea syndrome

open access: yesHuli yanjiu, 2018
Objective:To understand the status quo of care load and demand of the family caregivers of the children with obstructive sleep apnea hypopnea syndrome,and to explore the related influencing factors,to provide the basis for improving the care behaviors of
董菲菲   +5 more
doaj  

Home - About - Disclaimer - Privacy